Manufacturing
A company-reported network of eight facilities supports a broad healthcare portfolio.
HomeQUALITY & INNOVATION
QUALITY & INNOVATION
Scientific capability. A shared commitment to care.
A closer look at manufacturing, research and the information behind a considered partnership.
SANBE FARMA RESEARCH & DEVELOPMENT
LOOKING AHEAD
A place for the next question.
Sanbe’s published facilities profile includes formulation research and a biotechnology division established in 2001. These capabilities provide a starting point for research and strategic collaboration.
Discuss a research collaborationResearch & biotechnology
Formulation and biotechnology work create room for scientific partnerships.
Quality information
Dated inspection summaries help partners identify the relevant plant and document scope.
PUBLISHED INSPECTION INFORMATION
Know the facility. Understand the scope.
Summaries of WHO public inspection reports published by Sanbe Farma. These historical records do not establish current certification or approval for every product.
Penicillin plant · Unit II
The WHO report covers an inspection at Cimahi, including oral penicillin formulations. The inspection covered amoxicillin dispersible tablets; several other production areas and dosage forms were outside its scope.
Source: WHO Public Inspection Report, PT Sanbe Farma Penicillin Plant, February 2017.
Sterile preparations · Unit III
The report concerns Building A at Cimareme, West Bandung. Its inspection scope was limited to the Corima ampoule line, covering an oxytocin injection product; other listed sterile processes were outside that scope.
Source: WHO Public Inspection Report, PT Sanbe Farma Sterile Preparations Plant, February 2017.
For supplier qualification, request current documents for the relevant manufacturing site, product and destination market. Include these requirements in your partnership inquiry.
Where could we go together?
Share your market, your priorities and the opportunity you see.